Thermoreversible Hydrogel Compositions for Cardiac Stem Cell Retention

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for delivering therapeutic stem cells to damaged cardiac tissue are inefficient, leading to uncontrolled spreading and potential adverse effects, while existing hydrogels lack the mechanical properties to withstand the beating environment and maintain cell viability.

Innovation Solution

A biodegradable thermoreversible hydrogel is used to embed stem cells, which adheres to the scar site beneath the pericardium, providing a supportive scaffold that maintains cell viability and controlled release, with adjustable mechanical properties to withstand heart contractions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If stem cells are delivered to damaged cardiac tissue using current methods, then cell delivery is achieved, but the cells spread uncontrolled and cause potential adverse effects

Engineering Contradiction:
Improvecontrolled cell deliveryVSAvoiduncontrolled spreading
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent uses an injectable hydrogel as an intermediary carrier system to deliver stem cells to the damaged cardiac tissue. The hydrogel acts as a temporary scaffold that confines the cells at the injection site, preventing uncontrolled spreading while maintaining cell viability and facilitating controlled release over time.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If hydrogels are used to embed stem cells, then cell retention is improved, but the hydrogel lacks mechanical properties to withstand heart contractions

Engineering Contradiction:
Improvecell retentionVSAvoidmechanical properties
Core Design Contradiction:
ReliabilityVSStrength

Solution Approach 1:

The patent modifies the hydrogel's physical and chemical parameters to achieve both cell retention and mechanical durability. The hydrogel formulation includes specific polymer ratios, cross-linking densities, and structural characteristics that enable it to withstand the mechanical stress of heart contractions while maintaining its ability to embed and retain stem cells.

Inventive Principle:
Principle #35Parameter changes

3Reliability

If hydrogels are used as supportive scaffold, then cell viability is maintained, but the hydrogel may be washed out due to weak mechanical properties

Engineering Contradiction:
Improvecell viabilityVSAvoidresistance to washout
Core Design Contradiction:
ReliabilityVSStability of the object's composition

Solution Approach 1:

The patent employs a composite hydrogel material that combines multiple polymer components with different functional properties. This composite structure provides both the biochemical support needed for cell viability and the mechanical strength required to resist washout by body fluids, creating a stable scaffold that persists long enough to facilitate tissue regeneration.

Inventive Principle:
Principle #40Composite materials

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The hydrogel effectively retains stem cells at the treatment site for prolonged periods, enhancing therapeutic efficacy by preventing systemic spread and ensuring controlled cell delivery and duration.

Implementation Method 1

biodegradable thermoreversible hydrogels

Methodology Applied
Scientific EffectThermoreversible phase change: Phase Change

Implementation Method 2

adheres to the scar site beneath the pericardium

Methodology Applied
Scientific EffectAdhesion: Adhesive

Data Source

PatentUS12390494B2Compositions and methods for treating heart disease
Publication Date: 2025.08.19 HOLZER(IL)
  • US12390494B2 patent drawing

AI summary

The present invention provides methods and compositions for treating damage to the heart tissue. In particular, the present invention provides pharmaceutical compositions comprising stem cells embedded in biocompatible thermoreversible hydrogels and use thereof in treating myocardium infarction.